Valley Forge Asset Management’s VanEck Biotech ETF BBH Stock Holding History

Valley Forge Asset Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$5.45M	Sell	42,965 -4,675	-10%	-$573K	0.85%	53
2015 Q3	$5.45M	Buy	+47,640	New	+$6.31M	0.86%	55

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Valley Forge Asset Management's BBH Position: Q4 2015 in Review

Valley Forge Asset Management reduced its VanEck Biotech ETF (BBH) stake by 9.8% in Q4 2015, selling an estimated $573K and leaving 42,965 shares worth $5.45M. The position accounts for 0.85% of the portfolio, ranked #53.

Valley Forge Asset Management first reported a position in BBH in Q3 2015 and has held it in 2 quarters since. 90 funds tracked by Wall St. Rank hold BBH as of Q4 2015.

Valley Forge Asset Management held 42,965 shares of VanEck Biotech ETF worth $5.45M as of Q4 2015.
Valley Forge Asset Management sold 4,675 VanEck Biotech ETF shares in Q4 2015, an estimated $573K.
VanEck Biotech ETF made up 0.85% of Valley Forge Asset Management's portfolio in Q4 2015, its #53 holding.
Valley Forge Asset Management first reported a position in VanEck Biotech ETF in Q3 2015 and has held it in 2 quarters since.
90 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2015.

Based on Valley Forge Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.